Survey of Ophthalmology
Volume 47, Issue 1 , Pages 63-67, January 2002

Primary Drug Treatment for Glaucoma:☆☆★★♢♢

Beta-Blockers Versus Other Medications

  • Robert L. Stamper, MD

      Affiliations

    • Corresponding Author InformationReprint address: Robert L. Stamper, MD, UCSF Deptartment of Ophthalmology, 10 Kirkham Street, Room K-301, San Francisco, CA 94121

Department of Ophthalmology, University of California, San Francisco, CA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 I. Individualize Initial Therapy

☆☆ Robert L. Stamper, MD

 II. Choosing Beta-Blockers for Initial Medical Therapy for Glaucoma

★★ Stephen A. Wigginton, MD and Eve J. Higginbotham, MD

 Abstract. This set of Viewpoints articles examines the merits of beta-blockers versus other medications as the primary drug treatment for glaucoma. Ophthalmologists must balance issues such as efficacy, compliance, cost, and side effects when deciding on the appropriate medication to prescribe. Dr. Stamper stresses the advantages of tailoring the choice of medication to the needs of the individual patient. Drs. Wigginton and Higginbotham review the benefits of beta-blockers and present some of the disadvantages of the non-beta-blocker class of medications. (Surv Ophthalmol 47:63–73, 2002. © 2002 by Elsevier Science Inc. All rights reserved.)

♢♢ Key words. beta-blockers • compliance • cost • glaucoma • side effects

 The author has no commercial or proprietary interest in any product or concept discussed in this article.

PII: S0039-6257(01)00286-7

Survey of Ophthalmology
Volume 47, Issue 1 , Pages 63-67, January 2002